ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Therapeutic Potential of Human Liver-Derived Stem Cell Transplantation in a Cirrhotic Liver Rat Model.

S. Lee,1 J.-H. Lee,2 H.-J. Park,2 Y.-A. Kim,2 M.-N. Park,2 S.-K. Lee.1

1Department of Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea
2Stem Cell and Regenerative Medicine Center, Samsung Medical Center, Seoul, Republic of Korea.

Meeting: 2016 American Transplant Congress

Abstract number: D44

Keywords: Liver cirrhosis, Stem cells

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Chimerism/Stem Cells, Cellular/Islet Transplantation, Innate Immunity, Chronic Rejection

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Human Bone Marrow Mesenchymal Stem Cell-Derived Hepatocytes Express TIMP-4 and Follistatin
  • Effect of Adipose Tissue-Derived Mesenchymal Stem Cells in a Rat Model of Chronic Renal Allograft Rejection.

Cirrhosis is a long-term consequence of chronic hepatic injury and there are no effective treatment methods. Previous studies suggested that MSCs may ameliorate fibrogenesis through the inhibition of hepatic stellate cells (HSCs) activation. Previously we have reported that human liver-derived stem cells (HLSCs) could be isolated and expanded from donated liver not suitable for liver transplantation. HLSCs show mesenchymal morphology and grow well under serum conditions. Also they express some surface antigens of MSCs but are neither hematopoietic nor oval cells. When they are sequentially exposed to growth factors or cytokines they became round or polygonal and express hepatic markers, such as albumin, a-1-antitrypsin etc in the gene or protein level. The aim of this study was to assess the effectiveness of HLSCs in improving liver fibrosis.

Six week-old Sprague-Dawley rats were treated with carbon tetra-chloride (CCl4) by intraperitoneal injection twice a week for 8 weeks. Rats were injected with 1.2 ml/kg CCl4 to induce liver damage and progressive liver fibrosis. HLSCs were injected into the rats through the portal vein after partial hepatectomy. After 4 weeks of HLSCs transplants, rats exhibited a significant reduction in liver fibrosis, as evidenced by Sirius Red staining, compared with rats without HLSCs transplants. Matrix metalloproteinase-2 (MMP-2), tissue inhibitor of metalloprotease (TIMP) and transforming growth factor beta (TGFβ) were detected with real-time reverse transcriptase-polymerase chain reaction.

Biochemical and histopathological analyses showed significantly increased recovery from liver damage in the HLSCs transplanted group. In addition, HLSCs transplantation increased MMP-2, and decreased TIMP expression, and liver fibrosis was significantly decreased. HLSCs may stimulate MMP production in fibrotic livers, contributing to extracellular matrix (ECM) degradation and hepatic regeneration.

In conclusion, our data suggest that HLSCs may facilitate recovery from chronic liver damage and may decrease liverfibrosis by stimulating MMP production in a rat liver fibrosis model.

CITATION INFORMATION: Lee S, Lee J.-H, Park H.-J, Kim Y.-A, Park M.-N, Lee S.-K. The Therapeutic Potential of Human Liver-Derived Stem Cell Transplantation in a Cirrhotic Liver Rat Model. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lee S, Lee J-H, Park H-J, Kim Y-A, Park M-N, Lee S-K. The Therapeutic Potential of Human Liver-Derived Stem Cell Transplantation in a Cirrhotic Liver Rat Model. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/the-therapeutic-potential-of-human-liver-derived-stem-cell-transplantation-in-a-cirrhotic-liver-rat-model/. Accessed February 24, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Weight Loss, But Not Weight Gain Is a Risk Factor for Graft Loss After Kidney Transplantation

      Visit Our Partner Sites

      American Transplant Congress (ATC)

      Visit the official site for the American Transplant Congress »

      American Journal of Transplantation

      The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

      American Society of Transplantation (AST)

      An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

      American Society of Transplant Surgeons (ASTS)

      The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

      Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

      Privacy Policy

      loading Cancel
      Post was not sent - check your email addresses!
      Email check failed, please try again
      Sorry, your blog cannot share posts by email.
      This site uses cookies: Find out more.